Solara Active Pharma Sciences Limited

NSE BSE

Performance

Today's Low		Today's High
762.25 762.45		784.40 781.00

52 Week Low		52 Week High
291.33 (21-Dec-2023) 292.27 (21-Dec-2023)		882.80 (02-Dec-2024) 885.95 (02-Dec-2024)

Open: 784.40 780.65

Previous Close: 779.85 779.80

Volume: 0.88

Total Traded value: 6.80 (₹ Lakhs)

Upper circuit: 857.80 495.95

Lower circuit: 701.90 330.65

Market Depth

Buy Order Quantity		Sell Order Quantity
25		0

Bid Price	Quantity
770.70	25.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	25

Ask Price	Quantity
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	--

Fundamentals

Market Cap:	₹27.91 Cr
PE Ratio (TTM):	-6.98
PB Ratio:	3.43
Industry P/E:	0.00
Debt to Equity:	-

ROE:	-49.14
EPS (TTM):	-111.67
Book Value:	229.15
Face Value:	10.00

Financials

	Sep, 2022	Mar, 2023	Sep, 2023	Mar, 2023	Sep, 2022
Revenue	60.54 Cr	43.39 Cr	131.10 Cr	38.90 Cr	338.37 Cr
Profit	17.21 Cr	29.43 Cr	3.73 Cr	10.06 Cr	-9.91 Cr
Expense	47.54 Cr	72.76 Cr	132.59 Cr	26.42 Cr	361.37 Cr
Comprehensive income	17.21 Cr	29.43 Cr	3.72 Cr	9.27 Cr	-10.99 Cr
EPS	5.38	0.65	0.43	3.49	-2.75

Solara Active Pharma Sciences Limited, based in Chennai, India, engages in the manufacturing, processing, formulation, sale, import, export, merchandising, distribution, trade, and dealing of active pharmaceutical ingredients (API). The company specializes in providing APIs across various therapeutic categories such as anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes.

The company also offers contract research and manufacturing services for APIs, encompassing contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. Solara Active Pharma Sciences Limited operates both domestically and internationally, serving regions such as the Asia Pacific, Europe, North America, and South America. Formerly known as SSL Pharma Sciences Limited, the company rebranded as Solara Active Pharma Sciences Limited in March 2017, with its establishment dating back to the year 2017.

Company name	Listing date	Industry	NSE symbol BSE symbol
Solara Active Pharma Sciences Limited	Jun, 2018 Jun, 2018	Pharmaceuticals Pharmaceuticals	SOLARA SOLARA

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

Promoters

37.19%
Public

62.81%
Shares held by Employee Trusts

0.00%
Promoters

39.31%
Public

60.69%
Shares held by Employee Trusts

0.00%
Promoters

40.97%
Public

59.03%
Shares held by Employee Trusts

0.00%
Promoters

40.40%
Public

59.60%
Shares held by Employee Trusts

0.00%
Promoters

40.40%
Public

59.60%
Shares held by Employee Trusts

0.00%

Promoters
	37.19%

Public
	62.81%

Shares held by Employee Trusts
	0.00%

Promoters
	39.31%

Public
	60.69%

Shares held by Employee Trusts
	0.00%

Promoters
	40.97%

Public
	59.03%

Shares held by Employee Trusts
	0.00%

Promoters
	40.40%

Public
	59.60%

Shares held by Employee Trusts
	0.00%

Promoters
	40.40%

Public
	59.60%

Shares held by Employee Trusts
	0.00%

Solara Active Pharma Sciences Limited FAQ's

What is the range of today's stock performance for Solara Active Pharma Sciences Limited?

Today's stock performance witnessed a fluctuation from a minimum of 762.25 on the NSE (National Stock Exchange) to a maximum of 784.40. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 762.45 to a high of 781.00.

What are the 52-week low and high values for Solara Active Pharma Sciences Limited?

The stock's performance over the past 52 weeks reveals a low of 291.33 (occurred on 21-Dec-2023) and a high of 882.80 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 292.27 (on 21-Dec-2023), and the 52-week high is 885.95 (on 02-Dec-2024).

What was the opening and previous closing prices for Solara Active Pharma Sciences Limited?

The stock's performance over the past 52 weeks reveals a low of 291.33 (occurred on 21-Dec-2023) and a high of 882.80 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 292.27 (on 21-Dec-2023), and the 52-week high is 885.95 (on 02-Dec-2024).

What is the total volume and traded value for Solara Active Pharma Sciences Limited for the day?

The total volume is 1, and the total traded value is 6.80 (₹ Lakhs).

What are the upper and lower circuit limits for Solara Active Pharma Sciences Limited?

The upper circuit limit is 857.80, and the lower circuit limit is 701.90.

What is the market cap and PE ratio for Solara Active Pharma Sciences Limited?

The market cap is ₹27.91 Cr, and the PE ratio (TTM) is 0.00.

What is the PB ratio, industry P/E, and debt to equity ratio for Solara Active Pharma Sciences Limited?

The PB ratio is 3.38, industry P/E is 0.00 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Solara Active Pharma Sciences Limited?

ROE is -49.14, EPS is -111.67, book value is 229.15

What are the revenue and profit figures for the latest quarter and previous quarters for Solara Active Pharma Sciences Limited?

In Sep 2022, Revenue is ₹605399000, and Profit is ₹172140000. In Mar 2023, Revenue is ₹433919000.00, and Profit is ₹294292000.00.

When was Solara Active Pharma Sciences Limited listed, and what industry does it belong to?

The company, Solara Active Pharma Sciences Limited, was listed in Jun 2018 and belongs to the Pharmaceuticals industry. Its NSE symbol is SOLARA.

What is the current shareholding pattern of the Solara Active Pharma Sciences Limited?

As of latest available update, promoters hold 37.19%, the public holds 62.81%, and Employee Trusts holds 0.00.

Search

Navigation section